Podcast Index
Explora podcasts por categoría, abre episodios recientes y descarga audio para escucharlo sin conexión.
Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
Her Intentional Reset
Molly Wipperfurth
SunCast
Nico Johnson
Eye On The Sky
Vermont Public
Skeptoid
Brian Dunning
Muddy Boots
Keith and Elisabeth
Don't Eat Poop! A Food Safety Podcast
Food Safety Specialists: Matthew Regusci and Francine L Shaw
The Joy of Trek
Kay, Khaki and Greg
Up North Report
KAXE / KBXE News
Brain Based Parenting
Cal Farley's
Science In Your Shopping Cart
USDA Agricultural Research Service
Chicago Weather Daily
Fast Foundations
Clima Diario Ciudad de México
Fast Foundations
The Veterinary Culture Lab
Flourish Veterinary Consulting
Invisible Force
CAIREreporting.org & Tobias Gilk
Daily Short Stories - Ghost and Horror Stories
Sol Good Network
Neville Goddard Daily
Neville Goddard
Science Fiction - Daily Short Stories
Sol Good Network
Stories - Science Fiction
Sol Good Network
Daily Science Fiction Stories
solgoodmedia.com
Daily Ghost and Horror Stories
solgoodmedia.com
SciFi Cast
solgoodmedia.com
Mind Webs Radio
solgoodmedia.com
Science Fiction Radio Hour
solgoodmedia.com
Mind Webs
solgoodmedia.com
Quiet Please
Wyllis Cooper
Classic Radio Science Fiction
solgoodmedia.com
Time Traveler's Radio
solgoodmedia.com
Daily Short Stories - Science Fiction
Public Domain Books
The Adventures of Superman
Dashiell Hammett
Science Fiction Radio
solgoodmedia.com
Timeless Sci-Fi Radio
solgoodmedia.com
Galactic Sci-Fi Broadcasts
solgoodmedia.com
Pioneer Sci-Fi Radio
solgoodmedia.com
Future Worlds Radio
solgoodmedia.com
Vintage Sci-Fi Radio
solgoodmedia.com
Interstellar Sci-Fi Tunes
solgoodmedia.com
Ciencia
David Brühlmann - CMC Development Leader, Bioprocess Expert, Business Strategist
What if the simple act of opening an incubator could undermine the consistency of your cell therapy manufacturing process? Unlike traditional biologics, the moment cells leave their incubator, subtle shifts in temperatur...
Digital transformation in biotech is no longer just about adopting new tools, it's about building a foundation where automation, data standardization, and AI integration actually lead to real value and long-term success....
Despite cutting-edge equipment and brilliant minds, biotech labs often find half their data trapped in difficult-to-access spreadsheets or isolated in silos, making true digital transformation a major, industry-wide hurd...
Host David Brühlmann returns for a focused solo episode to provide an honest, data-driven perspective on the evolving landscape of host selection for biologics manufacturing. Building on part one, David reviews five alte...
In this solo episode, David Brühlmann explores the evolving landscape of biologic manufacturing platforms beyond CHO (Chinese hamster ovary) cells. Drawing from previous interviews with platform pioneers and rigorous dat...
Funding novel therapeutics isn’t just “harder than ever”—the rules have changed entirely. The wild rush of capital into early-stage biotech during 2020–2021 gave way to a drought, making investor priorities sharper and s...
Strong science alone won’t get your biotech startup funded—investors are sizing up much more than just your molecule.Michael Rome, who leads therapeutics investing at Foresite Capital, brings a rare dual lens as both sci...
What happens between scientific discovery and clinical trials? For too many drug candidates, the answer is “failure”—not because the idea lacked merit, but because the critical handoff between discovery and IND-enabling ...
The gap between a “drug” and a true “product” is where many therapies fail.Milan Tomic, biotech veteran, GMP manufacturing expert, and founder of Albrem, has spent 30 years turning promising science into scalable, execut...
The "data lake" that was supposed to unify bioprocessing intelligence has, in most companies, become something else entirely: a data swamp, where information goes in and insight rarely comes back out. For anyone trying t...
When AI can draft a literature review in minutes, the question bioprocess educators can no longer avoid is this: what does a student actually need to learn?Steffen Kreye has a clear answer. As Professor of Industrial Bio...
Can aging be fundamentally slowed or even reversed—not by science fiction, but by harnessing the unassuming power of super-early stem cells?In Part 1, Yuta Lee, Founder and CEO of Accelerated Bio, walked through the biol...
What if the key to scalable, off-the-shelf cell therapy was hiding in tissue that surgeons discard every day?Yuta Lee, Founder and CEO of Accelerated Bio, has spent two decades building a cell therapy platform on exactly...
Are you still using one-factor-at-a-time experiments for biosimilar development, losing months, missing interactions, and risking costly dead-ends?In this episode, David Brühlmann, host of the Smart Biotech Scientist Pod...
Are you stuck screening endless compounds in biosimilar development and still not hitting your quality targets? Efficient compound screening is one of the toughest bottlenecks in biopharma, with outdated methods slowing ...
When every batch belongs to a single patient, a single centralized facility cannot serve the world. In Part 2, Chantale Bernatchez moves from process development into the broader consequences of that reality: the manufac...
The most underappreciated parameter in cell therapy process development is not your bioreactor, your media, or your activation protocol. It is the patient. Chantale Bernatchez has spent 20 years learning that lesson the ...
Getting an NDA signed shouldn't take weeks. If your CRO needs more than 48 hours to start the paperwork, your project timeline is already moving in the wrong direction.Ron Najafi knows what rigorous analytical work actua...
When drug safety fails, patients and entire markets pay the price. Understanding your CMC isn't just compliance — it's the line between therapeutic promise and product recall.Ron Najafi has lived that reality firsthand. ...
Shear sensitivity is the silent challenge behind many advanced biomanufacturing modalities. Orbital-shaken bioreactors—often underestimated—may be a key enabler your CMC development is missing.Tibor Anderlei, CSO at Kühn...
Completa el formulario de abajo. Asegúrate de seleccionar tanto País como Géneros.
Envíanos un mensaje abajo. Te responderemos en un plazo de 24 horas.